Skip to main content
Clinical Trials/CTRI/2022/11/047091
CTRI/2022/11/047091
Not Yet Recruiting
Phase 3

Effectiveness of injectable platelet rich fibrin (i-PRF) with combination periodontal regenerative therapy in the management of infrabony defects: A randomized controlled clinical trial

Dr Anu John0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: K053- Chronic periodontitis
Sponsor
Dr Anu John
Status
Not Yet Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Anu John

Eligibility Criteria

Inclusion Criteria

  • 1\.Adults above18 years diagnosed with periodontitis (according to AAP 2017 classification) after step 1 and step 2 therapy (non\-surgical phase) with the presence of atleast one site with 2 or 3 walled interproximal infrabony defects in either of the jaws
  • 2\.Systemically healthy subjects
  • 3\.Full mouth bleeding score\<\= 30 % and Full mouth plaque score \<\=20%

Exclusion Criteria

  • 1\.Current tobacco users
  • 2\.Subjects taking medications affecting the periodontium (Bisphosphonates, Calcium channel blockers, cyclosporine, steroids, phenytoin )
  • 3\.Pregnancy or lactation
  • 4\.Antibiotic medication in the last 3 months
  • 5\.Infrabony defects that are indicated for resective therapy.
  • 6\.Grade II /II furcation involvement

Outcomes

Primary Outcomes

Not specified

Similar Trials